BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 29397940)

  • 1. KSHV vIRF4 enhances BCL6 transcription via downregulation of IRF4 expression.
    Yu HR; Kim YJ; Lee HR
    Biochem Biophys Res Commun; 2018 Feb; 496(4):1128-1133. PubMed ID: 29397940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4) targets expression of cellular IRF4 and the Myc gene to facilitate lytic replication.
    Lee HR; Doğanay S; Chung B; Toth Z; Brulois K; Lee S; Kanketayeva Z; Feng P; Ha T; Jung JU
    J Virol; 2014 Feb; 88(4):2183-94. PubMed ID: 24335298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of IRF4 induces lytic reactivation of KSHV in primary effusion lymphoma cells.
    Forero A; McCormick KD; Jenkins FJ; Sarkar SN
    Virology; 2014 Jun; 458-459():4-10. PubMed ID: 24928034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
    Smith CG; Kharkwal H; Wilson DW
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma.
    Manzano M; Günther T; Ju H; Nicholas J; Bartom ET; Grundhoff A; Gottwein E
    mBio; 2020 Aug; 11(4):. PubMed ID: 32843547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperation between viral interferon regulatory factor 4 and RTA to activate a subset of Kaposi's sarcoma-associated herpesvirus lytic promoters.
    Xi X; Persson LM; O'Brien MW; Mohr I; Wilson AC
    J Virol; 2012 Jan; 86(2):1021-33. PubMed ID: 22090118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global epigenomic analysis of KSHV-infected primary effusion lymphoma identifies functional
    Park A; Oh S; Jung KL; Choi UY; Lee HR; Rosenfeld MG; Jung JU
    Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21618-21627. PubMed ID: 32817485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of IRF4 in IFN-stimulated gene induction and maintenance of Kaposi sarcoma-associated herpesvirus latency in primary effusion lymphoma cells.
    Forero A; Moore PS; Sarkar SN
    J Immunol; 2013 Aug; 191(3):1476-85. PubMed ID: 23804715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication Is Independent of Anaphase-Promoting Complex Activity.
    Elbasani E; Gramolelli S; Günther T; Gabaev I; Grundhoff A; Ojala PM
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 4 (vIRF4) Perturbs the G1-S Cell Cycle Progression via Deregulation of the cyclin D1 Gene.
    Lee HR; Mitra J; Lee S; Gao SJ; Oh TK; Kim MH; Ha T; Jung JU
    J Virol; 2016 Jan; 90(2):1139-43. PubMed ID: 26491150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor suppressor pathway.
    Lee HR; Toth Z; Shin YC; Lee JS; Chang H; Gu W; Oh TK; Kim MH; Jung JU
    J Virol; 2009 Jul; 83(13):6739-47. PubMed ID: 19369353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Herpesvirus 8 Interferon Regulatory Factors 1 and 3 Mediate Replication and Latency Activities via Interactions with USP7 Deubiquitinase.
    Xiang Q; Ju H; Li Q; Mei SC; Chen D; Choi YB; Nicholas J
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KSHV activates unfolded protein response sensors but suppresses downstream transcriptional responses to support lytic replication.
    Johnston BP; Pringle ES; McCormick C
    PLoS Pathog; 2019 Dec; 15(12):e1008185. PubMed ID: 31790507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
    Lan K; Murakami M; Choudhuri T; Kuppers DA; Robertson ES
    Virology; 2006 Aug; 351(2):393-403. PubMed ID: 16701788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine gammaherpesvirus 68 reactivation from B cells requires IRF4 but not XBP-1.
    Matar CG; Rangaswamy US; Wakeman BS; Iwakoshi N; Speck SH
    J Virol; 2014 Oct; 88(19):11600-10. PubMed ID: 25078688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.
    King CA; Li X; Barbachano-Guerrero A; Bhaduri-McIntosh S
    J Virol; 2015 Nov; 89(22):11347-55. PubMed ID: 26339061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression.
    Sharma-Walia N; Raghu H; Sadagopan S; Sivakumar R; Veettil MV; Naranatt PP; Smith MM; Chandran B
    J Virol; 2006 Jul; 80(13):6534-52. PubMed ID: 16775340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target.
    Abere B; Mamo TM; Hartmann S; Samarina N; Hage E; Rückert J; Hotop SK; Büsche G; Schulz TF
    PLoS Pathog; 2017 Sep; 13(9):e1006639. PubMed ID: 28938025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4/K10) is a novel interaction partner of CSL/CBF1, the major downstream effector of Notch signaling.
    Heinzelmann K; Scholz BA; Nowak A; Fossum E; Kremmer E; Haas J; Frank R; Kempkes B
    J Virol; 2010 Dec; 84(23):12255-64. PubMed ID: 20861242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.